{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"286"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"295"}],"units":"Participants"}],"description":"The number of participants who experienced toxicity (defined as at least one grade 3 or higher adverse event at least possibly related to treatment) is reported below.","groups":[{"description":"Patients received induction (Course I), consolidation (Course II), interim maintenance (Course III), delayed intensification (Course IV), and long-term maintenance therapy (Course V). Please see the \"Detailed Description\" section for more information.","id":"OG000","title":"Treatment (Pediatric Regimen)"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Up to 10 years post-registration","title":"Number of Participants Who Experienced at Least One Grade 3 or Higher Adverse Event at Least Possibly Related to Treatment (Toxicity)","type":"PRIMARY","unitOfMeasure":"Participants"}